MYNN

Summary

MYNN (myoneurin, HGNC:14955) is a protein-coding gene on chromosome 3q26.2, encoding Myoneurin (Q9NPC7).

This gene encodes a member of the BTB/POZ and zinc finger domain-containing protein family that are involved in the control of gene expression. Alternative splicing results in multiple transcript variants and a pseudogene has been identified on chromosome 14.

Source: NCBI Gene 55892 — RefSeq curated summary.

At a glance

• GWAS associations: 16
• Clinical variants (ClinVar): 57 total
• Druggable target: yes
• MANE Select transcript: NM_018657

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:14955
Approved symbol	MYNN
Name	myoneurin
Location	3q26.2
Locus type	gene with protein product
Status	Approved
Aliases	SBBIZ1, ZBTB31, ZNF902
Ensembl gene	ENSG00000085274
Ensembl biotype	protein_coding
OMIM	606042
Entrez	55892

Gene structure

Transcript identifiers

Ensembl transcripts: 19 — 17 protein_coding, 2 nonsense_mediated_decay

ENST00000349841, ENST00000356716, ENST00000544106, ENST00000602391, ENST00000602751, ENST00000900706, ENST00000900707, ENST00000900708, ENST00000900709, ENST00000900710, ENST00000900711, ENST00000938902, ENST00000938903, ENST00000938904, ENST00000938905, ENST00000938906, ENST00000941309, ENST00000941310, ENST00000941311

RefSeq mRNA: 3 — MANE Select: NM_018657 NM_001185118, NM_001185119, NM_018657

CCDS: CCDS3207, CCDS54671

Canonical transcript exons

ENST00000349841 — 8 exons

Exon	Start	End
ENSE00001015017	169778768	169779561
ENSE00001366820	169774265	169774561
ENSE00001421558	169786416	169789716
ENSE00003324590	169773396	169773462
ENSE00003464361	169780590	169780749
ENSE00003513468	169784622	169784708
ENSE00003628147	169783477	169783560
ENSE00003641936	169782465	169782643

Expression profiles

Bgee: expression breadth ubiquitous, 274 present calls, max score 96.59.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 19.7830 / max 211.4608, expressed in 1782 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter ID	TPM avg	Samples expressed
39678	16.4487	1755
39675	2.5720	1331
39676	0.5352	320
39677	0.2271	80

Top tissues by expression

285 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
buccal mucosa cell	CL:0002336	96.59	gold quality
secondary oocyte	CL:0000655	96.23	gold quality
male germ line stem cell (sensu Vertebrata) in testis	CL:0000089 ∩ UBERON:0000473	89.20	gold quality
calcaneal tendon	UBERON:0003701	88.83	gold quality
oocyte	CL:0000023	88.10	gold quality
esophagus squamous epithelium	UBERON:0006920	86.49	gold quality
ventricular zone	UBERON:0003053	85.72	gold quality
amniotic fluid	UBERON:0000173	85.66	gold quality
ganglionic eminence	UBERON:0004023	85.66	gold quality
cortical plate	UBERON:0005343	85.33	gold quality
hindlimb stylopod muscle	UBERON:0004252	85.03	gold quality
gastrocnemius	UBERON:0001388	84.90	gold quality
hair follicle	UBERON:0002073	84.75	silver quality
islet of Langerhans	UBERON:0000006	84.73	gold quality
muscle of leg	UBERON:0001383	84.72	gold quality
cartilage tissue	UBERON:0002418	84.45	gold quality
parietal pleura	UBERON:0002400	84.29	gold quality
squamous epithelium	UBERON:0006914	84.19	gold quality
body of pancreas	UBERON:0001150	83.86	gold quality
stromal cell of endometrium	CL:0002255	83.54	gold quality
pancreas	UBERON:0001264	83.35	gold quality
tendon	UBERON:0000043	83.34	gold quality
germinal epithelium of ovary	UBERON:0001304	83.34	gold quality
pleura	UBERON:0000977	83.26	gold quality
rectum	UBERON:0001052	83.23	gold quality
epithelial cell of pancreas	CL:0000083	83.19	gold quality
sperm	CL:0000019	82.95	gold quality
muscle organ	UBERON:0001630	82.94	gold quality
endometrium	UBERON:0001295	82.90	gold quality
adrenal tissue	UBERON:0018303	82.88	gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

Experiment	Marker?	Max mean expression
E-ANND-3	no	0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

151 targeting MYNN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-3163	100.00	77.23	8605
HSA-MIR-5692A	100.00	74.40	6850
HSA-MIR-3646	100.00	73.56	5283
HSA-MIR-4283	100.00	66.42	2097
HSA-MIR-1277-5P	100.00	73.95	5056
HSA-MIR-4533	100.00	69.48	2758
HSA-MIR-4262	100.00	73.26	3931
HSA-MIR-3120-5P	100.00	65.56	965
HSA-MIR-4692	100.00	67.32	2066
HSA-MIR-548AW	99.99	72.57	3559
HSA-MIR-548C-3P	99.99	74.01	7587
HSA-MIR-4282	99.99	75.36	6408
HSA-MIR-34A-5P	99.99	71.21	1784
HSA-MIR-449A	99.99	71.05	1776
HSA-MIR-181A-5P	99.99	72.96	2995
HSA-MIR-181B-5P	99.99	72.97	2996
HSA-MIR-181C-5P	99.99	72.95	2996
HSA-MIR-181D-5P	99.99	73.04	2997
HSA-MIR-3662	99.99	73.82	5684
HSA-MIR-4803	99.98	71.99	3117
HSA-MIR-12136	99.98	72.81	5713
HSA-MIR-4775	99.98	75.00	6394
HSA-MIR-34C-5P	99.97	70.45	1577
HSA-MIR-449B-5P	99.97	70.26	1580
HSA-MIR-1468-3P	99.96	72.74	3797
HSA-MIR-5688	99.96	73.23	4504
HSA-MIR-495-3P	99.96	72.81	4197
HSA-MIR-548AJ-3P	99.96	73.38	5345
HSA-MIR-548X-3P	99.96	73.38	5345
HSA-MIR-548AT-5P	99.96	70.83	2666

Literature-anchored findings (GeneRIF, showing 2)

• there may exist an association between a combination of MYNN rs10936599 and TERC rs2293607 polymorphisms and development of bladder cancer in Turkish population. (PMID:30120764)
• Comprehensive characterization of coding and non-coding single nucleotide polymorphisms of the Myoneurin (MYNN) gene using molecular dynamics simulation and docking approaches. (PMID:38165846)

Cross-species orthologs

2 orthologs

Organism	Symbol	Gene ID
mus_musculus	Mynn	ENSMUSG00000037730
rattus_norvegicus	Mynn	ENSRNOG00000027923

Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)

Protein

Protein identifiers

Myoneurin — Q9NPC7 (reviewed: Q9NPC7)

Alternative names: Zinc finger and BTB domain-containing protein 31

All UniProt accessions (2): Q9NPC7, R4GMT1

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Nucleus.

Tissue specificity. Mainly expressed in the neuromuscular system. Located in and around synaptic myonuclei in adult muscle. Expression is dysregulated after nerve injury. Also found in the testis, ovary and placenta.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (4)

UniProt ID	Names	Canonical?
Q9NPC7-1	1	yes
Q9NPC7-2	2
Q9NPC7-3	3
Q9NPC7-4	4, m4b

RefSeq proteins (3): NP_001172047, NP_001172048, NP_061127* (*=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR000210	BTB/POZ_dom	Domain
IPR011333	SKP1/BTB/POZ_sf	Homologous_superfamily
IPR013087	Znf_C2H2_type	Domain
IPR036236	Znf_C2H2_sf	Homologous_superfamily

Pfam: PF00096, PF00651, PF13912

UniProt features (35 total): zinc finger region 8, helix 6, splice variant 5, compositionally biased region 3, region of interest 2, short sequence motif 2, sequence conflict 2, strand 2, turn 2, chain 1, domain 1, modified residue 1

Structure

Experimental structures (PDB)

1 structures.

PDB	Method	Resolution (Å)
2VPK	X-RAY DIFFRACTION	2

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-Q9NPC7-F1	64.90	0.29

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 289

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 137 (showing top): RNGTGGGC_UNKNOWN, GOBP_RESPONSE_TO_PEPTIDE, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN, chr3q26, YY1_Q6, YY1_02, SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP, DODD_NASOPHARYNGEAL_CARCINOMA_UP, BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP, MODULE_544, DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER, ACEVEDO_LIVER_CANCER_UP, TGCCTTA_MIR124A, GCCATNTTG_YY1_Q6

GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), cellular response to leukemia inhibitory factor (GO:1990830)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (2): nucleoplasm (GO:0005654), nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
RNA polymerase II transcription regulatory region sequence-specific DNA binding	2
regulation of DNA-templated transcription	1
transcription by RNA polymerase II	1
cellular response to cytokine stimulus	1
response to leukemia inhibitory factor	1
cis-regulatory region sequence-specific DNA binding	1
chromatin	1
DNA-binding transcription factor activity	1
regulation of transcription by RNA polymerase II	1
transition metal ion binding	1
nucleic acid binding	1
binding	1
cation binding	1
nuclear lumen	1
cellular anatomical structure	1
intracellular membrane-bounded organelle	1

Protein interactions and networks

STRING

1478 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
MYNN	LRRC34	Q8IZ02	810
MYNN	ACTRT3	Q9BYD9	722
MYNN	LRRIQ4	A6NIV6	721
MYNN	LRRC31	Q6UY01	583
MYNN	RHPN2	Q8IUC4	517
MYNN	PREPL	Q4J6C6	453
MYNN	ZNF800	Q2TB10	439
MYNN	CUEDC2	Q9H467	436
MYNN	GPR160	Q9UJ42	435
MYNN	DARS2	Q6PI48	423
MYNN	FBXO28	Q9NVF7	416
MYNN	ECH1	Q13011	405
MYNN	FAM170A	A1A519	399
MYNN	ZBTB24	O43167	396
MYNN	OLIG3	Q7RTU3	387

IntAct

54 interactions, top by confidence:

A	B	Type	Score
ANP32B	MYNN	psi-mi:“MI:0915”(physical association)	0.560
FDXACB1	MYNN	psi-mi:“MI:0915”(physical association)	0.560
CALR	MYNN	psi-mi:“MI:0915”(physical association)	0.560
SERPINH1	MYNN	psi-mi:“MI:0915”(physical association)	0.560
MYNN	CDH1	psi-mi:“MI:0915”(physical association)	0.560
DLST	MYNN	psi-mi:“MI:0915”(physical association)	0.560
DMWD	MYNN	psi-mi:“MI:0915”(physical association)	0.560
MYNN		psi-mi:“MI:0915”(physical association)	0.560
GRN	MYNN	psi-mi:“MI:0915”(physical association)	0.560
PRKN	MYNN	psi-mi:“MI:0915”(physical association)	0.560
MYNN	TGFBR2	psi-mi:“MI:0915”(physical association)	0.560
CDK5R1	MYNN	psi-mi:“MI:0915”(physical association)	0.560
KIF1B	MYNN	psi-mi:“MI:0915”(physical association)	0.560
MYNN	JPH3	psi-mi:“MI:0915”(physical association)	0.560
MYNN	NEK7	psi-mi:“MI:0915”(physical association)	0.560

BioGRID (16): MYNN (Affinity Capture-MS), MYNN (Affinity Capture-MS), ANP32B (Two-hybrid), FDXACB1 (Two-hybrid), MYNN (Proximity Label-MS), MYNN (Affinity Capture-MS), MYNN (Affinity Capture-MS), MYNN (Two-hybrid), MYNN (Cross-Linking-MS (XL-MS)), NEK1 (Cross-Linking-MS (XL-MS)), MYNN (Affinity Capture-RNA), MYNN (Affinity Capture-MS), MYNN (Two-hybrid), MYNN (Affinity Capture-RNA), MYNN (Affinity Capture-MS)

ESM2 similar proteins: A1L1J6, A2ANX9, A7Y7X5, E9Q8T2, G5E8B9, O15060, O43167, O43829, O62836, O95625, P08048, P0C6P6, P10925, P17010, P17012, P20662, P52739, Q01611, Q08376, Q0VCB0, Q2FAY8, Q3TTC2, Q4V8R6, Q52V16, Q5DU09, Q5PPG4, Q5R5M1, Q5R5N5, Q5RAU9, Q5SVQ8, Q6B4Z5, Q6GNP2, Q6INV8, Q7TS63, Q7ZVR6, Q80V63, Q80X44, Q811F1, Q8K3J5, Q92010

Diamond homologs: A0JN76, A1L2U9, A1YEX3, A1YPR0, A2AAX3, B1WAZ8, B1WBS3, B1WBU4, B2RXF5, D3ZA50, O14867, O15062, O15156, O15209, O43167, O43298, O43829, O88282, O88939, O93567, O95365, P24278, P41182, P41183, P52739, P97302, P97303, Q08376, Q0IH98, Q0IJ29, Q0P4X6, Q0VCJ6, Q13105, Q14526, Q1H9T6, Q1L8W0, Q2T9Z7, Q3B725, Q3B7N9, Q3SWU4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

57 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	45
Likely benign	0
Benign	0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1029 predictions. Top by Δscore:

Variant	Effect	Δscore
3:169778766:A:AG	acceptor_gain	1.0000
3:169778767:G:GG	acceptor_gain	1.0000
3:169779542:GCAT:G	donor_gain	1.0000
3:169780587:TAG:T	acceptor_loss	1.0000
3:169780588:A:AG	acceptor_gain	1.0000
3:169780588:AG:A	acceptor_gain	1.0000
3:169780588:AGGT:A	acceptor_gain	1.0000
3:169780589:G:GA	acceptor_gain	1.0000
3:169780589:GG:G	acceptor_gain	1.0000
3:169780589:GGT:G	acceptor_gain	1.0000
3:169780589:GGTG:G	acceptor_gain	1.0000
3:169780589:GGTGA:G	acceptor_gain	1.0000
3:169780698:AT:A	donor_gain	1.0000
3:169780750:G:GA	donor_loss	1.0000
3:169780751:T:A	donor_loss	1.0000
3:169784616:TTTCA:T	acceptor_loss	1.0000
3:169784617:TTCAG:T	acceptor_loss	1.0000
3:169784618:TCA:T	acceptor_loss	1.0000
3:169784619:CA:C	acceptor_loss	1.0000
3:169784620:A:AG	acceptor_gain	1.0000
3:169784620:AG:A	acceptor_gain	1.0000
3:169784621:G:A	acceptor_loss	1.0000
3:169784621:G:GG	acceptor_gain	1.0000
3:169784621:GG:G	acceptor_gain	1.0000
3:169784621:GGA:G	acceptor_gain	1.0000
3:169784683:G:GT	donor_gain	1.0000
3:169784707:TGGT:T	donor_loss	1.0000
3:169784709:G:GG	donor_gain	1.0000
3:169784709:GT:G	donor_loss	1.0000
3:169784710:T:A	donor_loss	1.0000

AlphaMissense

4049 scored. Top likely-pathogenic:

Variant	Protein change	am_pathogenicity
3:169779495:T:C	C332R	1.000
3:169779516:T:C	F339L	1.000
3:169779517:T:C	F339S	1.000
3:169779518:T:A	F339L	1.000
3:169779518:T:G	F339L	1.000
3:169779535:T:C	L345P	1.000
3:169779545:T:A	H348Q	1.000
3:169779545:T:G	H348Q	1.000
3:169779557:T:A	H352Q	1.000
3:169779557:T:G	H352Q	1.000
3:169780628:T:C	F367L	1.000
3:169780629:T:C	F367S	1.000
3:169780630:T:A	F367L	1.000
3:169780630:T:G	F367L	1.000
3:169780694:T:C	C389R	1.000
3:169780703:T:C	C392R	1.000
3:169780715:T:C	F396L	1.000
3:169780716:T:C	F396S	1.000
3:169780717:T:A	F396L	1.000
3:169780717:T:G	F396L	1.000
3:169780734:T:C	L402P	1.000
3:169782493:T:C	C417R	1.000
3:169782502:T:C	C420R	1.000
3:169782514:T:C	F424L	1.000
3:169782515:T:C	F424S	1.000
3:169782516:T:A	F424L	1.000
3:169782516:T:G	F424L	1.000
3:169782533:T:C	L430P	1.000
3:169782541:C:A	H433N	1.000
3:169782541:C:G	H433D	1.000

dbSNP variants (sampled 300 via entrez): RS1000107656 (3:169781869 A>G), RS1000135495 (3:169778972 A>C,G), RS1000176719 (3:169789834 A>G), RS1000184827 (3:169775623 C>G,T), RS1000214547 (3:169775942 G>T), RS1000434071 (3:169790117 C>T), RS1000550070 (3:169777484 T>C,G), RS1000747482 (3:169780526 C>A,G,T), RS1001215006 (3:169784501 A>G), RS1001359775 (3:169784095 C>G), RS1001374430 (3:169776772 C>T), RS1001731438 (3:169785006 T>G), RS1001967208 (3:169771708 C>G), RS1002123681 (3:169776982 G>A,C), RS1002236020 (3:169776608 A>C)

Disease associations

OMIM: gene MIM:606042 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

16 associations (top):

Study	Trait	p-value
GCST000843_3	Colorectal cancer	3.000000e-08
GCST001198_51	Multiple sclerosis	7.000000e-07
GCST002140_2	Multiple myeloma	9.000000e-14
GCST002243_3	Bladder cancer	5.000000e-09
GCST002299_1	Chronic lymphocytic leukemia	2.000000e-09
GCST002922_5	Multiple myeloma and monoclonal gammopathy	7.000000e-06
GCST004744_12	Lung adenocarcinoma	5.000000e-06
GCST005996_58	Red blood cell count	4.000000e-08
GCST007552_26	Colorectal cancer	2.000000e-06
GCST007856_90	Colorectal cancer or advanced adenoma	8.000000e-06
GCST008834_3	Non-small cell lung cancer	2.000000e-10
GCST009869_52	Colorectal cancer	9.000000e-06
GCST010303_21	Nevus count or cutaneous melanoma	5.000000e-16
GCST010304_1	Cutaneous malignant melanoma	4.000000e-11
GCST011956_77	Systemic lupus erythematosus	2.000000e-11
GCST012396_4	Multiple myeloma	3.000000e-08

EFO canonical traits (2, from GWAS)

EFO ID	Trait name
EFO:0004305	erythrocyte count
EFO:0004632	nevus count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL5069362 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

38 total (human), top 30 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
Valproic Acid	affects expression, affects cotreatment, decreases expression	4
Formaldehyde	increases expression	2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide	decreases expression	1
TAK-243	increases sumoylation	1
dicrotophos	decreases expression	1
methylmercuric chloride	decreases expression, increases expression	1
triphenyl phosphate	affects expression	1
tris(1,3-dichloro-2-propyl)phosphate	increases expression	1
sodium arsenite	increases expression	1
butyraldehyde	increases expression	1
cupric oxide	increases expression	1
celastrol	decreases expression	1
di-n-butylphosphoric acid	affects expression	1
cylindrospermopsin	increases expression	1
CGP 52608	affects binding, increases reaction	1
gedunin	decreases expression	1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	affects cotreatment, decreases expression	1
abrine	increases expression	1
dorsomorphin	affects cotreatment, decreases expression	1
(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)	increases expression	1
jinfukang	decreases expression	1
Resveratrol	affects cotreatment, increases expression	1
Sunitinib	increases expression	1
Benzene	decreases expression	1
Calcitriol	decreases expression, affects cotreatment	1
Demecolcine	decreases expression	1
Doxorubicin	decreases expression	1
Ethyl Methanesulfonate	increases expression	1
Folic Acid	increases expression	1
Gold	decreases expression	1

ChEMBL screening assays

2 unique, capped per target: 2 binding

Representative assays (with source publication via chembl_document):

Assay ID	Type	Description	Source paper
CHEMBL5059495	Binding	Proteomics fold change data (SUDHL4 cells, 1h)	Data for DCP probe CCT369260

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_HC85	HEK293 eGFP-MYNN	Transformed cell line	Female

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.